NASDAQ:INNV InnovAge (INNV) Stock Price, News & Analysis $3.05 -0.02 (-0.65%) Closing price 04:00 PM EasternExtended Trading$3.03 -0.02 (-0.66%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About InnovAge Stock (NASDAQ:INNV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get InnovAge alerts:Sign Up Key Stats Today's Range$3.03▼$3.1350-Day Range$2.63▼$3.5152-Week Range$2.60▼$6.69Volume31,398 shsAverage Volume52,749 shsMarket Capitalization$412.49 millionP/E RatioN/ADividend YieldN/APrice Target$5.00Consensus RatingReduce Company OverviewInnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.Read More… InnovAge Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks29th Percentile Overall ScoreINNV MarketRank™: InnovAge scored higher than 29% of companies evaluated by MarketBeat, and ranked 753rd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.8 / 5Analyst RatingReduce Consensus RatingInnovAge has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageInnovAge has received no research coverage in the past 90 days.Read more about InnovAge's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for InnovAge are expected to grow in the coming year, from ($0.12) to $0.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InnovAge is -16.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of InnovAge is -16.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInnovAge has a P/B Ratio of 1.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about InnovAge's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.30% of the float of InnovAge has been sold short.Short Interest Ratio / Days to CoverInnovAge has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in InnovAge has recently increased by 2.17%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInnovAge does not currently pay a dividend.Dividend GrowthInnovAge does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.30% of the float of InnovAge has been sold short.Short Interest Ratio / Days to CoverInnovAge has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in InnovAge has recently increased by 2.17%, indicating that investor sentiment is decreasing. News and Social Media3.0 / 5News Sentiment1.41 News SentimentInnovAge has a news sentiment score of 1.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for InnovAge this week, compared to 1 article on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, InnovAge insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.40% of the stock of InnovAge is held by insiders.Percentage Held by InstitutionsOnly 12.26% of the stock of InnovAge is held by institutions.Read more about InnovAge's insider trading history. Receive INNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter. Email Address INNV Stock News HeadlinesInnovAge to Announce Fiscal Third Quarter 2025 Financial Results and Host Conference Call Tuesday, May 6, 2025April 22, 2025 | globenewswire.comWall Street Set to Open Mixed Thursday as Investors Parse Key Employment, Manufacturing DataApril 17, 2025 | msn.comThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.April 28, 2025 | Paradigm Press (Ad)InnovAge Champions PACE at State Capitols to Protect Critical Care for SeniorsApril 17, 2025 | globenewswire.comInnovAge Announces Participation at the KeyBanc Capital Markets Healthcare ForumMarch 4, 2025 | globenewswire.comInnovAge Reports Mixed Sentiment in Latest Earnings CallFebruary 5, 2025 | tipranks.comInnovAge reaffirms FY2025 guidance with revenue projected between $815M and $865MFebruary 5, 2025 | msn.comInnovAge Holding Corp. (INNV) Q2 2025 Earnings Call TranscriptFebruary 5, 2025 | seekingalpha.comSee More Headlines INNV Stock Analysis - Frequently Asked Questions How have INNV shares performed this year? InnovAge's stock was trading at $3.93 at the start of the year. Since then, INNV shares have decreased by 22.4% and is now trading at $3.05. View the best growth stocks for 2025 here. How were InnovAge's earnings last quarter? InnovAge Holding Corp. (NASDAQ:INNV) released its quarterly earnings data on Tuesday, February, 4th. The company reported ($0.10) earnings per share for the quarter. InnovAge had a negative net margin of 3.19% and a negative trailing twelve-month return on equity of 9.45%. Read the conference call transcript. When did InnovAge IPO? InnovAge (INNV) raised $301 million in an initial public offering (IPO) on Thursday, March 4th 2021. The company issued 16,700,000 shares at a price of $17.00-$19.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup served as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers. How do I buy shares of InnovAge? Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InnovAge own? Based on aggregate information from My MarketBeat watchlists, some other companies that InnovAge investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), NVIDIA (NVDA), Meta Platforms (META), Netflix (NFLX) and Home Depot (HD). Company Calendar Last Earnings2/04/2025Today4/28/2025Next Earnings (Estimated)5/06/2025Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryHealthcare Current SymbolNASDAQ:INNV CIK1834376 Webwww.innovage.com Phone844-803-8745FaxN/AEmployees2,000Year FoundedN/APrice Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+63.9%Consensus RatingReduce Rating Score (0-4)1.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-21,340,000.00 Net Margins-3.19% Pretax Margin-3.24% Return on Equity-9.45% Return on Assets-4.84% Debt Debt-to-Equity Ratio0.27 Current Ratio1.16 Quick Ratio1.16 Sales & Book Value Annual Sales$806.61 million Price / Sales0.51 Cash FlowN/A Price / Cash FlowN/A Book Value$1.90 per share Price / Book1.61Miscellaneous Outstanding Shares135,244,000Free Float133,351,000Market Cap$412.49 million OptionableOptionable Beta0.41 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:INNV) was last updated on 4/28/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share InnovAge With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.